Home > Insider Trading > Filing (0001209191-19-003544)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1264783	Cm Wilhelmus Groenhuysen	C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-01-10	25	$27.20	37,149	No	4	A	Direct
Ordinary Shares	Acquisiton	2019-01-11	30,000	$3.44	67,149	No	4	M	Direct
Ordinary Shares	Disposition	2019-01-11	30,000	$42.35	37,149	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2019-01-11	30,000	$0.00	30,000	$3.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
464,663		2021-12-13	No	4	M	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2018 through December 31, 2018. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 2, 2018.
Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.
Options exercised were fully vested as of the date hereof.